Occam Recruits Sales and Operations Leader to the Board of Geron
In March 2019, Occam Global recruited Dawn C. Bir to the Board of Geron Corporation, a public commercial-stage oncology biotech. Bir also serves on the Board of Soleno Therapeutics and was the Chief Commercial Officer at Reata Pharmaceuticals from September 2016 until Biogen’s $7.3B acquisition of Reata in 2023. Prior to her time at Reata, she held several key leadership positions at Pharmacyclics, McKesson, Genentech, and Bristol-Myers Squibb, demonstrating a strong track record in sales, operations, and team development across various therapeutic areas.
Read more about Occam's work with Geron in our case study.
Recent Placements
- Carolyn Haley as COO at F-Prime Capital
- Chau Cheng as VP of Investor Relations & Corporate Communications at Cytomx
- Bryan Stuart as CEO of Atavistik
- Bimal Shah as CFO of Corium
- Bell Zhong as CFO at Neomorph
- Occam Recruits Sapna Srivastava to the Board of Nuvalent
- Occam's Tech Practice Places CRO at Engageli
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.